Form 4: National Healthcare Corp Director Exercises Stock Options
SEC Form 4 Filing
Richard F. LaRoche Jr., a director at National Healthcare Corp, exercised options to purchase 5,000 shares of common stock at $64.64 on May 5, 2025.
Summary
- On May 5, 2025, Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), exercised options to purchase 5,000 shares of common stock at a price of $64.64 per share.
- This transaction was executed under the company's 2020 Omnibus Equity Incentive Plan.
- Following the transaction, LaRoche directly owns 205,912 shares of common stock.
- LaRoche also has indirect ownership through a ROTH IRA (114,8327 shares), Family LP (30,000 shares), Fam. Partnership (LR Ent.) (28,000 shares), and Fam. Partnership (LFLP) (96,000 shares).
- LaRoche continues to hold options to purchase additional shares of common stock at various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction (option exercise) by a director. While it can be seen as a positive signal, it's not overwhelmingly so.
Positives
- The exercise of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Comparing the option exercise price and the director's holdings to those of peers in the healthcare industry could provide a benchmark for assessing the significance of this transaction.
- For example, comparing the percentage of shares owned by Richard F. LaRoche Jr. to the percentage of shares owned by directors at Brookdale Senior Living or Welltower Inc. could provide a benchmark for assessing the significance of this transaction.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/07/2020 | Date of grant for the exercised stock options under the 2020 Omnibus Equity Incentive Plan. |
| 05/07/2021 | Exercisable date for Option to Purchase Common Stock [2020 Grant]. |
| 05/06/2022 | Exercisable date for Option to Purchase Common Stock [2021 Grant]. |
| 05/05/2023 | Exercisable date for Option to Purchase Common Stock [2022 Grant]. |
| 05/04/2024 | Exercisable date for Option to Purchase Common Stock [2023 Grant]. |
| 05/05/2025 | Date of transaction: Director exercised stock options; Exercisable date for Option to Purchase Common Stock [2024 Grant]. |
| 05/06/2025 | Expiration date for Option to Purchase Common Stock [2020 Grant]. |
| 05/05/2026 | Expiration date for Option to Purchase Common Stock [2021 Grant]. |
| 05/04/2027 | Expiration date for Option to Purchase Common Stock [2022 Grant]. |
| 05/03/2028 | Expiration date for Option to Purchase Common Stock [2023 Grant]. |
| 05/08/2029 | Expiration date for Option to Purchase Common Stock [2024 Grant]. |
Keywords
stock options, director, exercise, National Healthcare Corp, NHC, Form 4, insider trading, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.